Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Apr-24 7:00 PM View:  | Mahoney David L Director | Corcept Therapeutics Inc. (CORT) | 10-Apr-24 | Acquisition (other) | 27,806 | -- | -- | 2% 1.26M to 1.29M | |
| 12-Apr-24 7:00 PM View: | Mahoney David L Director | Corcept Therapeutics Inc. (CORT) | 10-Apr-24 | Disposition (other) | 27,806 | -- | -- | (2%) 1.31M to 1.29M | |
| 12-Apr-24 7:00 PM View: | Mahoney David L Director | Corcept Therapeutics Inc. (CORT) | 10-Apr-24 | Payment of Exercise | 2,194 | $23.80 | $52,217.20 | (< 1%) 1.32M to 1.31M | |
| 12-Apr-24 7:00 PM View: | Mahoney David L Director | Corcept Therapeutics Inc. (CORT) | 10-Apr-24 | Option Exercise | 30,000 | $1.74 | $52,200.00 | 2% 1.29M to 1.32M | |
| 08-Apr-24 6:16 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 04-Apr-24 | Planned Option Sale | 5,443 | $26.00 | $141,524.00 | (43%) 12.76K to 7.31K | |
| 08-Apr-24 6:16 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 04-Apr-24 | Option Exercise | 5,443 | $11.35 | $61,778.10 | 74% 7.31K to 12.76K | |
| 03-Apr-24 8:00 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Apr-24 | Planned Option Sale | 500 | $26.01 | $13,003.50 | (6%) 7.81K to 7.31K | |
| 03-Apr-24 8:00 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Apr-24 | Option Exercise | 500 | $11.35 | $5,675.00 | 7% 7.31K to 7.81K | |
| 03-Apr-24 7:38 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Apr-24 | Option Exercise | 2,200 | $5.86 | $12,892.00 | 100% 0 to 2.2K | |
| 03-Apr-24 7:38 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Apr-24 | Planned Option Sale | 2,200 | $25.30 | $55,660.00 | (100%) 2.2K to 0 | |
| 29-Mar-24 2:12 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 27-Mar-24 | Option Exercise | 25,953 | $3.88 | $100,698.00 | 25% 105.22K to 131.18K | |
| 29-Mar-24 2:12 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 27-Mar-24 | Planned Option Sale | 25,953 | $25.01 | $649,025.00 | (20%) 131.18K to 105.22K | |
| 20-Mar-24 5:09 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 19-Mar-24 | Option Exercise | 10,000 | $2.61 | $26,100.00 | 11% 95.22K to 105.22K | |
| 20-Mar-24 5:09 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 18-Mar-24 | Option Exercise | 17,219 | $3.88 | $66,809.70 | 18% 95.22K to 112.44K | |
| 20-Mar-24 5:09 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 18-Mar-24 | Planned Option Sale | 17,219 | $25.00 | $430,475.00 | (15%) 112.44K to 95.22K | |
| 05-Mar-24 9:02 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Planned Option Sale | 2,200 | $23.59 | $51,898.00 | (100%) 2.2K to 0 | |
| 05-Mar-24 9:19 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Payment of Exercise | 474 | $24.06 | $11,404.40 | (6%) 7.79K to 7.31K | |
| 05-Mar-24 9:14 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Grant | 1,272 | $12.03 | $15,302.20 | 1% 94.45K to 95.73K | |
| 05-Mar-24 9:03 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Grant | 1,108 | $12.03 | $13,329.20 | 12% 8.95K to 10.05K | |
| 05-Mar-24 8:41 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Grant | 1,394 | $12.03 | $16,769.80 | 5% 28.16K to 29.56K | |
| 05-Mar-24 9:02 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Option Exercise | 2,200 | $5.86 | $12,892.00 | 100% 0 to 2.2K | |
| 05-Mar-24 9:09 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Payment of Exercise | 604 | $24.06 | $14,532.20 | (9%) 6.64K to 6.04K | |
| 05-Mar-24 9:14 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Payment of Exercise | 505 | $24.06 | $12,150.30 | (< 1%) 95.73K to 95.22K | |
| 05-Mar-24 9:03 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Payment of Exercise | 517 | $24.06 | $12,439.00 | (5%) 10.05K to 9.54K | |
| 05-Mar-24 8:41 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Payment of Exercise | 656 | $24.06 | $15,783.40 | (2%) 29.56K to 28.9K | |
| 05-Mar-24 9:19 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 01-Mar-24 | Grant | 1,014 | $12.03 | $12,198.40 | 15% 6.77K to 7.79K | |
| 20-Feb-24 8:06 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 16-Feb-24 | Planned Option Sale | 27,068 | $25.97 | $702,904.00 | (22%) 121.52K to 94.45K | |
| 20-Feb-24 8:06 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 16-Feb-24 | Option Exercise | 27,068 | $3.61 | $97,810.50 | 29% 94.45K to 121.52K | |
| 21-Feb-24 9:11 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 16-Feb-24 | Option Exercise | 1,000 | $11.35 | $11,350.00 | 15% 6.77K to 7.77K | |
| 21-Feb-24 9:11 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 16-Feb-24 | Planned Option Sale | 1,000 | $26.00 | $26,000.00 | (13%) 7.77K to 6.77K | |
| 20-Feb-24 8:06 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 15-Feb-24 | Option Exercise | 4,760 | $3.29 | $15,660.40 | 5% 94.45K to 99.22K | |
| 20-Feb-24 8:06 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 15-Feb-24 | Planned Option Sale | 4,760 | $25.00 | $119,000.00 | (5%) 99.22K to 94.45K | |
| 02-Feb-24 5:39 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Feb-24 | Option Exercise | 2,200 | $5.86 | $12,892.00 | 100% 0 to 2.2K | |
| 02-Feb-24 5:39 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Feb-24 | Planned Option Sale | 2,200 | $22.00 | $48,400.00 | (100%) 2.2K to 0 | |
| 12-Jan-24 8:06 PM View: | Hunt Hazel Chief Scientific Officer | Corcept Therapeutics Inc. (CORT) | 08-Jan-24 | Payment of Exercise | 29,792 | $27.46 | $818,088.00 | (24%) 123.15K to 93.35K | |
| 12-Jan-24 8:06 PM View: | Hunt Hazel Chief Scientific Officer | Corcept Therapeutics Inc. (CORT) | 08-Jan-24 | Option Exercise | 50,000 | $3.02 | $151,000.00 | 68% 73.15K to 123.15K | |
| 04-Jan-24 7:14 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 02-Jan-24 | Option Exercise | 2,200 | $5.86 | $12,892.00 | 100% 0 to 2.2K | |
| 04-Jan-24 7:14 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 02-Jan-24 | Planned Option Sale | 2,200 | $22.11 | $48,642.00 | (100%) 2.2K to 0 | |
| 22-Dec-23 7:29 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 22-Dec-23 | Planned Private Option Sale | 10,000 | $32.00 | $320,000.00 | (60%) 16.64K to 6.64K | |
| 22-Dec-23 7:29 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 22-Dec-23 | Option Exercise | 10,000 | $19.26 | $192,600.00 | 151% 6.64K to 16.64K | (< 1%) |
| 19-Dec-23 6:21 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 15-Dec-23 | Gift | 750 | -- | -- | (2%) 30.09K to 29.34K | |
| 15-Dec-23 9:31 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 13-Dec-23 | Disposition (other) | 1,000 | -- | -- | (3%) 38.79K to 37.79K | |
| 12-Dec-23 8:46 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 08-Dec-23 | Gift | 1,917 | -- | -- | 7% 28.17K to 30.09K | |
| 06-Dec-23 8:56 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 06-Dec-23 | Option Sale | 6,212 | $27.01 | $167,786.00 | (17%) 35.66K to 29.45K | |
| 06-Dec-23 8:56 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 05-Dec-23 | Option Sale | 1,381 | $26.27 | $36,277.20 | (4%) 37.04K to 35.66K | |
| 06-Dec-23 8:56 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 04-Dec-23 | Payment of Exercise | 8,788 | $26.26 | $230,773.00 | (19%) 45.83K to 37.04K | |
| 05-Dec-23 6:59 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 04-Dec-23 | Option Exercise | 2,432 | $11.35 | $27,603.20 | 42% 5.85K to 8.29K | |
| 06-Dec-23 8:56 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 04-Dec-23 | Option Exercise | 15,000 | $3.29 | $49,350.00 | 49% 30.83K to 45.83K | |
| 05-Dec-23 6:59 PM View: | Lyon Joseph Douglas Chief Accounting Officer | Corcept Therapeutics Inc. (CORT) | 04-Dec-23 | Planned Option Sale | 2,432 | $26.00 | $63,232.00 | (29%) 8.29K to 5.85K | |
| 05-Dec-23 6:58 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Dec-23 | Option Exercise | 25,000 | $3.02 | $75,443.90 | 26% 94.45K to 119.45K |
